Studying Interventions for Managing Patients With Chronic Myeloid Leukemia (CML)in Chronic Phase: The 5-Year Prospective Cohort Study (SIMPLICITY).
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Dasatinib (Primary) ; Imatinib; Nilotinib
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- Acronyms SIMPLICITY
- Sponsors Bristol-Myers Squibb
- 07 Jul 2017 Planned End Date changed from 30 Jun 2018 to 30 Aug 2020.
- 07 Jul 2017 Planned primary completion date changed from 1 Jan 2018 to 30 Jan 2020.
- 20 Apr 2017 Planned End Date changed from 1 Jan 2018 to 30 Jun 2018.